HU209487B - Process for producing tetrahydro-naphtaline derivatives and pharmaceutical compositions containing them as active agents - Google Patents
Process for producing tetrahydro-naphtaline derivatives and pharmaceutical compositions containing them as active agents Download PDFInfo
- Publication number
- HU209487B HU209487B HU914021A HU402191A HU209487B HU 209487 B HU209487 B HU 209487B HU 914021 A HU914021 A HU 914021A HU 402191 A HU402191 A HU 402191A HU 209487 B HU209487 B HU 209487B
- Authority
- HU
- Hungary
- Prior art keywords
- formula
- alkyl
- tetrahydro
- defined above
- group
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
- C07C235/70—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups and doubly-bound oxygen atoms bound to the same carbon skeleton
- C07C235/72—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups and doubly-bound oxygen atoms bound to the same carbon skeleton with the carbon atoms of the carboxamide groups bound to acyclic carbon atoms
- C07C235/76—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups and doubly-bound oxygen atoms bound to the same carbon skeleton with the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of an unsaturated carbon skeleton
- C07C235/78—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups and doubly-bound oxygen atoms bound to the same carbon skeleton with the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of an unsaturated carbon skeleton the carbon skeleton containing rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/16—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2602/00—Systems containing two condensed rings
- C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
- C07C2602/04—One of the condensed rings being a six-membered aromatic ring
- C07C2602/10—One of the condensed rings being a six-membered aromatic ring the other ring being six-membered, e.g. tetraline
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Priority Applications (12)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| HU914021A HU209487B (en) | 1991-12-19 | 1991-12-19 | Process for producing tetrahydro-naphtaline derivatives and pharmaceutical compositions containing them as active agents |
| CA002126198A CA2126198A1 (en) | 1991-12-19 | 1992-12-18 | New tetrahydronaphthalene derivatives |
| PCT/HU1992/000058 WO1993012070A1 (en) | 1991-12-19 | 1992-12-18 | New tetrahydronaphthalene derivatives |
| NZ245534A NZ245534A (en) | 1991-12-19 | 1992-12-18 | Tetrahydronaphthalene derivatives and pharmaceutical compositions thereof |
| EP93901878A EP0618894A1 (en) | 1991-12-19 | 1992-12-18 | New tetrahydronaphthalene derivatives |
| JP5510766A JPH07502039A (ja) | 1991-12-19 | 1992-12-18 | 新規テトラヒドロナフタレン誘導体 |
| CN92113838A CN1074213A (zh) | 1991-12-19 | 1992-12-19 | 新的四氢化萘衍生物 |
| IL104196A IL104196A0 (en) | 1991-12-19 | 1992-12-20 | New tetrahydronaphthalene derivatives |
| ZA929913A ZA929913B (en) | 1991-12-19 | 1992-12-21 | New tetrahydronaphthalene derivatives. |
| TW081110291A TW223623B (enrdf_load_stackoverflow) | 1991-12-19 | 1992-12-21 | |
| FI942927A FI942927A0 (fi) | 1991-12-19 | 1994-06-17 | Menetelmä terapeuttisesti käyttökelpoisten tetrahydronaftaleenijohdannaisten valmistamiseksi |
| NO942306A NO942306L (no) | 1991-12-19 | 1994-06-17 | Nye tetrahydronaftalenderivater |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| HU914021A HU209487B (en) | 1991-12-19 | 1991-12-19 | Process for producing tetrahydro-naphtaline derivatives and pharmaceutical compositions containing them as active agents |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| HU914021D0 HU914021D0 (en) | 1992-03-30 |
| HUT63147A HUT63147A (en) | 1993-07-28 |
| HU209487B true HU209487B (en) | 1994-06-28 |
Family
ID=10966554
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU914021A HU209487B (en) | 1991-12-19 | 1991-12-19 | Process for producing tetrahydro-naphtaline derivatives and pharmaceutical compositions containing them as active agents |
Country Status (12)
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GR37790B (el) * | 1966-12-30 | 1969-07-15 | F. Hoffmann - La Roche & Co. Aktiengesellschaft | Μεθοδος δια την παρασκευην παραγωγων του αρουλακρυλικου οξεος. |
| HU198294B (en) * | 1987-06-10 | 1989-09-28 | Richter Gedeon Vegyeszet | Process for producing butenoic acid amides and pharmaceutical compositions comprising such active ingredient |
| HU198446B (en) * | 1987-09-25 | 1989-10-30 | Richter Gedeon Vegyeszet | Process for production of new amids of buten acid and medical compositions containing such active substances |
-
1991
- 1991-12-19 HU HU914021A patent/HU209487B/hu unknown
-
1992
- 1992-12-18 NZ NZ245534A patent/NZ245534A/en unknown
- 1992-12-18 EP EP93901878A patent/EP0618894A1/en not_active Withdrawn
- 1992-12-18 WO PCT/HU1992/000058 patent/WO1993012070A1/en not_active Application Discontinuation
- 1992-12-18 CA CA002126198A patent/CA2126198A1/en not_active Abandoned
- 1992-12-18 JP JP5510766A patent/JPH07502039A/ja active Pending
- 1992-12-19 CN CN92113838A patent/CN1074213A/zh active Pending
- 1992-12-20 IL IL104196A patent/IL104196A0/xx unknown
- 1992-12-21 ZA ZA929913A patent/ZA929913B/xx unknown
- 1992-12-21 TW TW081110291A patent/TW223623B/zh active
-
1994
- 1994-06-17 NO NO942306A patent/NO942306L/no unknown
- 1994-06-17 FI FI942927A patent/FI942927A0/fi not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| CN1074213A (zh) | 1993-07-14 |
| HU914021D0 (en) | 1992-03-30 |
| NO942306D0 (no) | 1994-06-17 |
| NO942306L (no) | 1994-06-17 |
| WO1993012070A1 (en) | 1993-06-24 |
| JPH07502039A (ja) | 1995-03-02 |
| NZ245534A (en) | 1995-07-26 |
| EP0618894A1 (en) | 1994-10-12 |
| HUT63147A (en) | 1993-07-28 |
| FI942927A7 (fi) | 1994-06-17 |
| IL104196A0 (en) | 1993-05-13 |
| ZA929913B (en) | 1993-06-24 |
| FI942927A0 (fi) | 1994-06-17 |
| CA2126198A1 (en) | 1993-06-24 |
| TW223623B (enrdf_load_stackoverflow) | 1994-05-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US6242432B1 (en) | Antithrombotic organic nitrates | |
| CA1288547C (en) | 1-(3-mercapto-2-methylpropanoyl) prolyl amino acid derivatives and salts thereof, processes for their preparation and pharmaceutical compositions containing such compounds | |
| HU215437B (hu) | Gyulladáscsökkentő és vérlemezke-aggregációt gátló salétromsav-észterek és eljárás előállításukra | |
| JPH06239822A (ja) | 新規なｎ−ベンゾイルアミノ酸誘導体、これらの化合物を含有する医薬組成物およびこれらの化合物を製造する方法 | |
| EP0611375A1 (en) | Peptides inhibiting il-1 beta release | |
| JP2007500684A (ja) | 心臓血管疾患治療用のアンギオテンシン−ｉｉ受容体遮断薬としてのロサルタン、バルサルタン、カンデサルタン、テルミサルタン、エプロサルタンおよびオルメサルタンのニトロオキシ誘導体 | |
| JPH08508720A (ja) | ピロールーアミジン化合物およびその薬剤的に受容できる塩、その製造法ならびにこれを含む医薬組成物 | |
| HU186983B (en) | Process for preparing new 3-amino-5-pregnene derivatives and salts thereof | |
| US6444849B1 (en) | Amide derivatives | |
| KR100209118B1 (ko) | 벤즈아미드 유도체 | |
| JP2603639B2 (ja) | チアゾリジン―４―カルボン酸化合物、その製造方法、この化合物を含有する解熱消炎鎮痛剤および虚血・リパーフュージョン症候群治療薬 | |
| WO2009076206A1 (en) | Synthesis methods of histone deacetylase inhibitors (hdacis) | |
| JPS6230762A (ja) | 新規５−オキソ−１−イミダゾリジンアセトアミド誘導体 | |
| JPH04356459A (ja) | 新規なベンジルコハク酸誘導体 | |
| HU209487B (en) | Process for producing tetrahydro-naphtaline derivatives and pharmaceutical compositions containing them as active agents | |
| LT3798B (en) | Method for the preparation of n,n'-bis(alkoxyalkyl)-pyrimidine-2,4-dicarboxylic acids diamides and use thereof | |
| US4456594A (en) | N-Carboxyalkylproline-containing tripeptides | |
| WO1992004369A1 (en) | 5-aminosalicylic acid derivatives for the therapy of chronic inflammatory bowel diseases | |
| JPH0635445B2 (ja) | イミダゾール含有ペプチド | |
| WO1997011052A1 (en) | Urea derivatives and their use as analgesics and antiinflammatory agents | |
| KR930006195B1 (ko) | 부텐산 아미드, 이들의 염, 이들을 함유하는 제약학적 조성물 및 이들의 제조방법 | |
| JPH1171336A (ja) | アミド誘導体 | |
| AU685980B2 (en) | Inhibition of leukotriene biosynthesis with urea derivatives | |
| JP3121118B2 (ja) | 新規なベンジルコハク酸誘導体 | |
| KR790001856B1 (ko) | 타이로신 유도체의 제조방법 |